Danish pharmaceutical firm Lundbeck has promoted Jacob Tolstrup to vice president, with responsibility for business development.
He will spearhead the development and strengthening of Lundbeck's current and future partnerships.
He will also explore growth opportunities in the form of inbound licensing of new drugs and potential acquisitions.
Tolstrup, who has been at Lundbeck for more than 10 years, was previously vp of finance and administration at Lundbeck’s American subsidiary, Lundbeck US.
Prior to this, he handled the firm’s investor relations and corporate communications as vp for corporate reporting, based at Lundbeck's headquarters in Valby.
‘Jacob has delivered strong results in a very professional manner for several years in various positions,’ said Ulf Wiinberg, chief executive of Lundbeck.
‘He also has significant experience in business development from the US market, which is of increasing strategic importance to us.’